Dystrophine Becker muscular dystrophy Ehlers‐Danlos Syndrome Centronuclear myopathy Allele-specific silencing therapy Biomarker Therapy Myologie Autophagosome maturation Titin GNE Diagnosis IPSC BiP Biological sciences Cardiac conduction system Rare neuromuscular diseases Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Gene therapy Alternative splicing CSF protein Connective tissue Laminopathies Maladies rares et orphelines Mutations Dilated cardiomyopathy A-type lamin Allele‐specific silencing therapy POPDC1 Heart failure CRISPR Skeletal muscle Rare diseases A-type lamins Regeneration Joint laxity Exome Dynamin 2 LMNA COL6A1 Calcium handling Actionability Myogenesis Acetyltransferase Muscle MRI Treatment Allele-specific silencing Laminopathie Lamin A/C COL1A1 Cancer biomarkers Treatment delay LGMD Muscle Patient registry Lamin A/C LMNA gene Butyrylcholinesterase Nuclear envelope LMNA-related congenital muscular dystrophy Mouse Muscle biopsy AAV Hypermobile EDS Neuromuscular diseases Lamin A/C nuclei Dystrophie musculaire Congenital muscular dystrophy Cancer Heart C elegans BVES COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders CMTX LMNA gene Muscular dystrophy Clinical trial C2C12 Laminopathy Duchenne muscular dystrophy Lamins Actionable gene COVID-19 Errance diagnostique Muscular dystrophy MD Myopathies Base de données FAIR Emery-Dreifuss muscular dystrophy RNA interference INPP5K Myopathy Angiotensin-converting enzyme inhibitors Emerin Myotubes Next generation sequencing Angiotensin-converting enzyme inhibitor Cardiomyopathy Adult SMA Maladies rares Cardiology AAV VECTOR